Embryonic stem cells induced pluripotent stem cells smad7 directly converts human embryonic stem cells to telencephalic fate by a default mechanism mohammad zeeshan ozair,scott noggle,aryeh warmflash,joanna ela krzyspiak,ali h. Pdf human embryonic and induced pluripotent stem cells in. Pluripotent stem cells pscs, including embryonic escs and induced pluripotent stem cells ipscs, offer immense potential as a source for regenerative therapies, as was recently recognized by the 2012 nobel committee in medicine. Bendavid u, benvenisty nthe tumorigenicity of human embryonic and induced pluripotent stem cells. Sep 29, 2010 embryonic stem cells escs and induced pluripotent stem cells ipscs have the ability i to duplicate indefinitely while maintaining pluripotency and ii to differentiate into cell types of all three embryonic germ layers. Efficient, selective removal of human pluripotent stem. Tissuebased products derived from induced pluripotent stem cells. Embryonic stem cells escs and induced pluripotent stem cells ipscs have the ability i to duplicate indefinitely while maintaining pluripotency and ii to differentiate into cell types of all three embryonic germ layers. This differentiation strategy derives from our knowledge of the embryonic notochordal lineage of np cells as well as strategies used to support healthy np cell phenotypes for primary cells in vitro. The recently developed and optimized induced pluripotent stem cells ipscs technology may provide an appealing access to overcome these challenges in ad research. The overall developmental dynamics of human primordial germ cells are similar to that in mice, but accumulating. Because of these abilities, numerous attempts have been made to utilize hpscs in regenerative medicinecell therapy. A schematic illustration of the generation and application of an autologous ipscbased cancer vaccine in patients.
However, a rapidly accumulating body of evidence suggests that there are important genetic and epigenetic. Although hematopoietic stem cell hsc therapy for hematological diseases can lead to a good outcome from the clinical point of view, the limited number of ideal donors, the comorbidity of patients and the increasing number of elderly patients may limit the application of this therapy. Stem cells hold great promise for regenerative medicine as they have the potential to repair almost any tissue. Efficient generation of transgenefree human induced pluripotent stem cells ipscs by temperaturesensitive sendai virus vectors. The tumorigenicity of human embryonic stem cells sciencedirect. The trials have used human embryonic stem cell hescderived retinal pigment epithelium rpe. Tumorigenicity studies of induced pluripotent stem cell. Tumorigenicity testing of mesenchymal stem cells may not reveal a serious problem 10. Dissecting the oncogenic and tumorigenic potential of.
Induced pluripotent stem cells ipscs for research and therapy. It was assumed that human induced pluripotent stem cells hipscs would behave like their embryonic counterparts in respect to their tumorigenicity, but a. The tumorigenicity of human embryonic and induced pluripotent stem cells. For full access to this pdf, sign in to an existing account, or purchase an annual subscription. Hideyuki okano, vicechair, cellular and tissue based products subcommittee. Generation of mouse induced pluripotent stem cells without.
In addition, several groups are planning clinical trials with autologous human induced pluripotent stem cell hipscderived rpe for the wet type of amd. Tumorigenicity studies for human pluripotent stem cell. Differentiation of human induced pluripotent stem cells into. Nevertheless, an issue that has slowed the use of ipsc as well as hesc in the clinic is safety. Hescs can be kept undifferentiated in culture or be differentiated to tissues representing all three germ layers, both in vivo and in vitro. Human pluripotent stem cells hpscs tend to acquire genomic aberrations in culture, the most common of which is trisomy of chromosome 12. Embryonic stem es cells and induced pluripotent stem ips cells are selfrenewing progenitors that have the capacity to differentiate into cells of the ectoderm, mesoderm, and endoderm.
Tumorigenicity of induced pluripotent stem cellderived neural stemprogenitor cells junhao deng, yiling zhang, yong xie, licheng zhang, and peifu tang department of orthopaedics, chinese pla general hospital, no. Then, in 1998, the first human embryonic stem cells hescs were isolated by james thomson in the usa 3. Human induced pluripotent stem cells ipscs are a type of stem cells that can be derived from human somatic cells by introducing certain transcription factors. These human induced pluripotent stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human es cells, and maintain. Tumorigenicity testing becomes particularly important when autologous human induced pluripotent stem cell ipscderived cell products with no immunobarrier are considered for transplantation. Human embryonic stem cells and induced pluripotent stem cells. Human embryonic stem cells hescs and induced pluripotent stem cells hipscs offer an immense potential as a source of cells for regenerative medicine. Another viable alternative is to induce stem cells from autologous somatic cells. Hipscs from somatic human cells was reported the following year. Spinal cord injury sci is an intractable and worldwide difficult medical challenge with limited treatments. Thus human pluripotent stem cells hpscs have an important role in biomedical research and future regenerative medicine, especially with the ability to reprogram somatic cells into induced pluripotent stem cells bendavid et al. Mouse clone model for evaluating the immunogenicity and. Current perspective on evaluation of tumorigenicity of cellular and tissuebased products derived from induced pluripotent stem cells ipscs and ipscs as their starting materials.
However, in the case of pscderived cell products, the tumorforming potential should be examined thoroughly because of the unlimited proliferation capacity of psc and their genetic instability. Genomewide screen for culture adaptation and tumorigenicity. Induced pluripotent stem cells ipscs for research and. Thus, cell therapy using human pluripotent stem cells hpscs has reached clinical application. These two key features make hpscs an ideal source of transplantable cells for medical and research purposes, which has raised hope that they could fundamentally change the way that many diseases are treated. However, the ability of undifferentiated hescs to produce tumors in vivo presents a major obstacle for the translation of this potential into clinical reality. The trials have used human embryonic stem cell hescderived retinal pigment epithelium rpe 14. Human embryonic stem cells hescs are pluripotent cells derived from the inner cell mass icm of a human blastocyst stage embryo thomson et al. Tatsutoshi nakahata, chair, cellular and tissue based products subcommittee. The promise of human induced pluripotent stem cells for research and therapy. Differential methylation of tissue and cancerspecific cpg island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Steps toward safe cell therapy using induced pluripotent.
Embryonic stem cells grown in mouse pluripotent stem cell media express pluripotency stem cell markers, ssea1 and oct34, and lack ssea4. Thus, cell therapy using human pluripotent stem cells hpscs has reached clinical. An insight into dnafree reprogramming approaches to generate. Embryonic stem cells induced pluripotent stem cells deconstructing stem cell tumorigenicity. More than a decade ago, a pioneering study reported generation of induced pluripotent stem cells ipscs by ectopic expression of a cocktail of reprogramming factors in fibroblasts. However, the fundamental question is still under debate whether stem cell based disease modeling and drug discovery are applicable for recapitulating pathological processes under in vivo conditions. Brivanlou laboratory of molecular embryology, the rockefeller university, new york, new york, usa. The discovery of induced pluripotent stem cells ipscs has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic and in laboratories. Induced pluripotent stem cells can divide indefinitely and are able to differentiate into every cell type, which make them viable for transplantation and individual disease modeling. These factors were chosen because they were known to be involved in the maintenance. Electrophysiological properties of human induced pluripotent stem cells peng jiang,1,2 stephanie n. The initial results from multiple clinical trials demonstrate that hescbased therapies are safe and promising. Human induced pluripotent stem cells and male infertility.
Isolate and culture pluripotent stem cells can be efficiently expanded in culture using specialized media and growth factors. Nov 11, 2018 more than a decade ago, a pioneering study reported generation of induced pluripotent stem cells ipscs by ectopic expression of a cocktail of reprogramming factors in fibroblasts. Rushing,1,2 chiwing kong,1,2,3,4 jidong fu,1,2 deborah kuoti lieu,1,2 camie w. The tumorigenicity of human embryonic and induced pluripotent stem cells until recently, it was assumed that human induced pluripotent stem cells hipscs would behave like their embryonic counterparts in respect to their tumorigenicity. To generate an autologous ipscbased cancer vaccine, peripheral blood mononuclear cells pbmcs are isolated from the patients blood and reprogrammed into induced pluripotent stem cells ipscs by the introduction of four yamanaka factors oct4, klf4, sox2, and cmyc. Here we dissect the cellular and molecular implications. Human induced pluripotent stem cells hipscs can be generated from patients somatic cells and in vitro derivation of functional germ cells from patientspecific ipscs may provide new therapeutic strategies for infertile couples. Pluripotent stem cells, both human embryonic stem cells hesc and human induced pluripotent stem cells hipsc, can give rise to multiple cell types and hence have tremendous potential for regenerative therapies. Aneuploidy induces profound changes in gene expression. It was assumed that human induced pluripotent stem cells hipscs would behave like their embryonic counterparts in respect to their tumorigenicity, but a rapidly accumulating body of evidence. Current perspective on evaluation of tumorigenicity of. Immunogenicity and tumorigenicity of human pluripotent stem.
Induced pluripotent stem cells ipscs and embryonic stem cells escs are two types of pluripotent stem cells that hold great promise for biomedical research and medical applications. An insight into dnafree reprogramming approaches to. Induced pluripotent stem cells in alzheimers disease. Human pluripotent stem cells hpscs have the potential to. The tumorigenic potential of pluripotent stem cells. Genomescale dna methylation maps of pluripotent and differentiated cells. Applications for the use of induced pluripotent stem cells and related concerns. Neural stemprogenitor cell nspc transplantation derived from fetal tissues or embryonic stem cells escs has demonstrated therapeutic effects via replacement of lost neurons and severed axons and creation of permissive microenvironment to promote repair of spinal cord and axon. It is remarkable that, to date, one of the most common assays for demonstrating and studying the pluripotency of stem cells, including induced pluripotent stem cells ipsc, is the teratoma assay. Induced pluripotent stem cells in medicine and biology. The tumorigenicity of human embryonic and induced pluripotent.
This report shed shadows on the great promise of ipscs as the renewable sources of autologous cells for regenerative medicine. Pluripotent stem cells, both human embryonic stem cells hesc and humaninduced pluripotent stem cells hipsc, can give rise to multiple cell types and hence have tremendous potential for regenerative therapies. Hence, the tumorigenicity of human embryonic stem cells hescs has been extensively studied. Basic studies of human pluripotential stem cells have advanced rapidly and stem cell products are now seeing therapeutic applications. Human embryonic stem cells hescs are the in vitro descendants of the pluripotent inner cell mass icm of human blastocyst stage embryos. Until recently, it was assumed that human induced pluripotent stem cells hipscs would behave like their embryonic counterparts in respect to their tumorigenicity. Because of the huge potential of human embryonic stem hes cells, especially the newly developed human induced pluripotent stem hips cells, in disease treatment and life quality improvement, enormous efforts have been made to develop new methodologies to translate lab discoveries in stem cell research into bedside clinical technologies. Therefore, human pscs hold great promise for regenerative medicine.
In 2007, okita and colleagues generated induced pluripotent cell lines from mouse embryonic. This study has revolutionized stem cell research and has garnered immense interest from the scientific community globally. Induced pluripotent stem ips cells in medicine and research. Li1,2,3,4 1institute of pediatric regenerative medicine, shriners hospital for children of north america, sacramento. Embryonic and induced pluripotent stem cells markers. Pluripotent stem cells pscs, including human embryonic stem cells hescs and induced pluripotent stem cells ipscs, are capable of unlimited selfrenewal and differentiating into all types of cells. Since the discovery of induced pluripotent stem cells ipscs, which have similar properties to hescs but less ethical issues than hescs, can be created directly. However, the tumorigenic potential of these cells remains a great concern, as reflected in the formation of teratomas by transplanted pluripotent cells. Design of a tumorigenicity test for induced pluripotent stem. The promise of induced pluripotent stem cells ipscs potentially more efficient integrative approaches. Differentiated cells can be reprogrammed to pluripotency and other cell fates by treatment with defined factors. Differentiation of human induced pluripotent stem cells. Human embryonic stem cells hescs are the first characterized pluripotent stem cells that could be induced to generate all types of cells including retinal neurons, for example, retinal pigment epithelium rpe cells 1, 2. Tumorigenicity as a clinical hurdle for pluripotent stem.
Induced pluripotent stem cells ipscs have immense potential to generate a variety of cell types for disease modeling, drug development, and cell therapy takahashi and yamanaka, 2006. The tumorigenicity of diploid and aneuploid human pluripotent. Induced pluripotent stem ips cells have been generated from mouse and human somatic cells by introducing oct34 and sox2 with either klf4 and cmyc or nanog and lin28 using retroviruses or lentiviruses. Why are there concerns over the safety of ips cells. Human pluripotent stem cells hpscs can be expanded indefinitely and differentiate into any cell type in the body. Embryonic stem cells or induced pluripotent stem cells. Design of a tumorigenicity test for induced pluripotent. Tumorigenicity as a clinical hurdle for pluripotent stem cell.
Here, we developed a new protocol for the efficient differentiation of human induced pluripotent stem cells hipscs into nplike cells in vitro. Apr 21, 2020 the tumorigenicity of human embryonic and induced pluripotent stem cells until recently, it was assumed that human induced pluripotent stem cells hipscs would behave like their embryonic counterparts in respect to their tumorigenicity. Induced pluripotent stem cell lines derived from human. Pdf bendavid u, benvenisty nthe tumorigenicity of human. Hematopoietic stem cells from induced pluripotent stem.
Tumorigenicity testing is therefore a key preclinical safety test in pscderived cell therapy. Mar 10, 2011 it was assumed that human induced pluripotent stem cells hipscs would behave like their embryonic counterparts in respect to their tumorigenicity, but a rapidly accumulating body of evidence. Neural stem progenitor cell nspc transplantation derived from fetal tissues or embryonic stem cells escs has demonstrated therapeutic effects via replacement of lost neurons and severed axons and creation of permissive microenvironment to promote repair of spinal cord and axon. Human embryonic and induced pluripotent stem cells. Proceedings of the national academy of sciences of the united states of america. In particular, the medical applications of human ipscs in disease modeling and stem cell therapy have been progressing. Tumorigenicity studies of induced pluripotent stem cell ipsc. Human induced pluripotent stem cells hipscs are discussed as disease modeling for optimization and adaptation of therapy to each individual.
Defining essential genes for human pluripotent stem cells by crisprcas9 screening in haploid cells. Immunogenicity and tumorigenicity of human pluripotent. Often this is referred to as a pluripotency assay, but of course it is also a tumor assay. Patientspecific ips cells could be useful in drug discovery and regenerative medicine. Induced pluripotent stem cells are similar to natural pluripotent stem cells, such as embryonic stem es cells, in many aspects, such as the expression of certain stem cell genes and proteins, chromatin methylation patterns, doubling time, embryoid body formation, teratoma formation, viable chimera formation, and potency and differentiability.
However, viral integration into the host genome increases the risk of tumorigenicity. The promise of induced pluripotent stem cells ipscs. Efficient, selective removal of human pluripotent stem cells. In particular, the medical applications of human ipscs in disease modeling and stem cell therapy have been. Tumorigenicity of induced pluripotent stem cellderived neural stem progenitor cells junhao deng, yiling zhang, yong xie, licheng zhang, and peifu tang department of orthopaedics, chinese pla general hospital, no. Here, we report the tumorigenic potential of induced pluripotent stem cell ipscderived retinal pigment epithelium rpe for the treatment of wettype, agerelated macular. However, questions remain regarding the tumorigenic potential of such cells. Frontiers induced pluripotent stem cellbased cancer. Hscs can be generated from induced pluripotent stem cells ipscs, which requires the understanding of the.
33 641 761 900 177 540 155 1217 587 299 320 726 569 1231 373 1043 1196 211 527 830 1215 161 343 1471 1009 776 1233 624 630 686 1056 1102 620 1282 577 1310 893 1307